Skip to content

Clinical trials

Phase 1/2 Emphysema trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Emphysema Phase: Phase 1/2 Country / region: United States Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20161
20171
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Adverum Biotechnologies, Inc.1
Grifols Therapeutics LLC1
Healeon Medical Inc1
Paul Szabolcs1
University of Washington1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Emphysema5
Pulmonary Disease, Chronic Obstructive5
Lung Diseases3
alpha 1-Antitrypsin Deficiency2
Bronchitis, Chronic1
Digestive System Diseases1
Genetic Diseases, Inborn1
Idiopathic Pulmonary Fibrosis1
Liver Diseases1
Lung Diseases, Obstructive1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.